Varian Medical EBITDA vs. Price To Book

Taking into consideration Varian Medical's profitability measurements, Varian Medical Systems may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Varian Medical's ability to earn profits and add value for shareholders.
For Varian Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Varian Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Varian Medical Systems utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Varian Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Varian Medical Systems over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please note, there is a significant difference between Varian Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Varian Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Varian Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Varian Medical Systems Price To Book vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Varian Medical's current stock value. Our valuation model uses many indicators to compare Varian Medical value to that of its competitors to determine the firm's financial worth.
Varian Medical Systems is rated first in ebitda category among its peers. It is rated first in price to book category among its peers . The ratio of EBITDA to Price To Book for Varian Medical Systems is about  72,245,179 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Varian Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Varian Price To Book vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Varian Medical

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
524.5 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Varian Medical

P/B

 = 

MV Per Share

BV Per Share

 = 
7.26 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Varian Price To Book Comparison

Varian Medical is currently under evaluation in price to book category among its peers.

Varian Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Varian Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Varian Medical will eventually generate negative long term returns. The profitability progress is the general direction of Varian Medical's change in net profit over the period of time. It can combine multiple indicators of Varian Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company was founded in 1948 and is headquartered in Palo Alto, California. Varian Medical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10000 people.

Varian Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Varian Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Varian Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Varian Medical's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Varian Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Use Investing Themes to Complement your Varian Medical position

In addition to having Varian Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Index Thematic Idea Now

Macroaxis Index
Macroaxis Index Theme
An experimental equal-weighted index theme of selected equities generated based on Macroaxis rating and scoring system. The Macroaxis Index theme has 52 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Index Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Varian Stock

If you are still planning to invest in Varian Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Varian Medical's history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Insider Screener
Find insiders across different sectors to evaluate their impact on performance